
Adults with AChR antibody–positive generalized myasthenia gravis now have a C5 inhibitor they can inject themselves at home once a week.
Top articles of the week on Specialty Pharmacy Times.
[<a href="//storify.com/pharmacytimes/nasp-conference-highlights-specialty-pharmacy-week" target="_blank">View the story "NASP Conference Highlights Specialty Pharmacy Week in Review" on Storify</a>]




